Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)

Project: Other project

Project Details

StatusFinished
Effective start/end date8/26/14 → 8/25/16

Funding

  • EMD Serono Inc: $5,346.16